4//SEC Filing
Maraoui Claude 4
Accession 0001104659-25-083217
CIK 0001867066other
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 9:54 PM ET
Size
9.3 KB
Accession
0001104659-25-083217
Insider Transaction Report
Form 4
Maraoui Claude
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Common Stock, $0.0001 par value
2025-08-25$0.07/sh+1,250,000$81,250→ 2,397,590 total - Tax Payment
Common Stock, $0.0001 par value
2025-08-25$7.47/sh−10,877$81,251→ 2,386,713 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-08-25−1,250,000→ 0 totalExercise: $0.07Exp: 2025-10-19→ Common Stock, $0.0001 par value (1,250,000 underlying)
Footnotes (2)
- [F1]Due to administrative error, the number of non-derivative securities beneficially owned by the reporting person was incorrectly reported as 2,397,590 instead of 1,147,590 on a Form 4 filed on June 20, 2025. This column reflects the corrected balance, as effected by the transactions reported on this Form 4.
- [F2]On October 19, 2015, the reporting person was granted 1,250,000 stock options pursuant to the Issuer's 2015 Stock Plan, as amended, that vested in accordance with the following schedule: 412,500 shares on January 7, 2016, 250,000 shares on September 22, 2016, 337,500 shares on January 7, 2017 and 250,000 shares on September 22, 2017. The 1,250,000 stock options are due to expire on October 19, 2025. Accordingly, the reporting person is exercising the stock options within the 60 days prior to the expiration date.
Documents
Issuer
Journey Medical Corp
CIK 0001867066
Entity typeother
Related Parties
1- filerCIK 0001893880
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 9:54 PM ET
- Size
- 9.3 KB